---
title: "Traws Pharma (TRAW.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/TRAW.US/norm.md"
symbol: "TRAW.US"
name: "Traws Pharma"
parent: "https://longbridge.com/zh-CN/quote/TRAW.US.md"
datetime: "2026-05-21T05:14:37.399Z"
locales:
  - [en](https://longbridge.com/en/quote/TRAW.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TRAW.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TRAW.US/norm.md)
---

# Traws Pharma (TRAW.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.5349 | -0.5768 | -0.3441 | -0.1100 | 2.09 |
| ROE | 766.60% | -1102.76% | -189.58% | -35.06% | -470.79% |
| 营业收入 | - | 0.0000 | - | 2.73M | 57000.00 |
| 净利润 | -5.69M | -5.40M | -3.04M | -625000.00 | 15.08M |
| 营业利润 | -6.95M | -7.37M | -4.05M | -1.25M | -5.20M |
| 毛利率 | - | - | - | 100.00% | 100.00% |
| 净利率 | - | - | - | -33.48% | 37701.75% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 8.16M | 10.62M | 12.44M | 15.62M | 19.06M |
| 权益乘数 | -1.54 | -16.88 | 2.74 | 1.89 | 3.18 |
| 每股净资产 | -0.5226 | -0.0694 | 0.6373 | 1.17 | 1.18 |
| 资产周转率 | 0.2008 | 0.1568 | 0.2662 | 0.1692 | 0.0122 |
| 现金及短投 | 3.13M | 3.82M | 6.42M | 13.08M | 15.94M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 6000.00 | 7000.00 | 7000.00 | 8000.00 | 9000.00 |
| 净债务 | -3.13M | -3.82M | -6.42M | -13.08M | -15.94M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -2.58M | -2.76M | -4.01M | -5.98M | -5.44M |
| 投资现金流 | - | 0.0000 | -2.58M | - | - |
| 融资现金流 | 1.90M | 158000.00 | -62000.00 | 3.10M | 13000.00 |
| 自由现金流 | -608250.00 | -1.93M | -5.35M | -3.09M | -3.53M |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |